Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Astellas licenses rights to Aquinox's rosiptor in Japan and Asia-Pacific countries

May 10, 2018

FDA clears Palladio to begin phase II study of lixivaptan in ADPKD

May 9, 2018

FDA approves Myrbetriq in combination with solifenacin for overactive bladder

May 8, 2018

Novel farnesoid X receptor agonists described by Enanta Pharmaceuticals

April 25, 2018

FDA approves Jynarque to slow kidney function decline in adults with ADPKD

April 25, 2018

Reata offers update on ongoing CARDINAL study of bardoxolone in Alport syndrome

April 12, 2018

Recordati acquires rights to Cystagon

April 9, 2018

Topline results from phase II study of fostamatinib in IgA nephropathy

April 4, 2018

Retrophin initiates pivotal phase III DUPLEX study of sparsentan

April 4, 2018

Urovant initiates phase III trial of vibegron in overactive bladder

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...